CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 28 filers reported holding CANCER GENETICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $66,000 | -77.2% | 272,818 | -2.0% | 0.01% | -68.8% |
| Q3 2018 | $289,000 | +17.5% | 278,260 | +0.7% | 0.02% | +6.7% |
| Q2 2018 | $246,000 | -36.8% | 276,417 | +17.4% | 0.02% | -46.4% |
| Q1 2018 | $389,000 | -17.4% | 235,502 | -7.5% | 0.03% | -24.3% |
| Q4 2017 | $471,000 | -26.5% | 254,461 | +7.2% | 0.04% | -30.2% |
| Q3 2017 | $641,000 | -13.7% | 237,431 | +26.3% | 0.05% | -22.1% |
| Q2 2017 | $743,000 | – | 188,060 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 581,200 | $1,157,000 | 1.33% |
| Fairbanks Capital Management, Inc. | 233,170 | $464,000 | 0.56% |
| DIKER MANAGEMENT LLC | 29,815 | $59,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 199,580 | $397,000 | 0.02% |
| Sterneck Capital Management, LLC | 14,750 | $29,000 | 0.02% |
| Spot Trading L.L.C | 151,900 | $302,000 | 0.01% |
| Acrospire Investment Management LLC | 3,514 | $7,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 84,320 | $168,000 | 0.01% |
| BECK MACK & OLIVER LLC | 18,225 | $36,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 47,600 | $94,000 | 0.00% |